FDA Approves Siemens Healthineers 0.55T MRI Scanner
Company’s smallest, most light-weight scanner receives approval.
Siemens Healthineers announced Tuesday it has received U.S. Food & Drug Administration approval for its 0.55T MAGENTOM Free.Max 80 cm MR Scanner.
This scanner is the company’s smallest and most lightweight, according to a company statement. As a High-V MR scanner, its 0.55T field strength combined with deep learning and advanced image processing not only make it useful across a wide range of clinical application, but as the first and only 80-cm bore, it can accommodate extremely obese or claustrophobic patients.
Credit: Siemens Healthineers
“Siemens Healthineers is proud to offer the MAGNETOM Free.Max, which brings MR to new clinical fields with innovative digital technology, new siting features, and image quality that was once realized only at higher field strengths,” said Jane Kilkenny, vice president of magnetic resonance at Siemens Healthineers North America. “The scanner’s comparatively low weight and size can open the door to MR utilization in orthopedic centers, emergency rooms, outpatient centers, and even intensive care units.”
The whole-body scanner itself weighs less than 3.5 tons, is less than 80 inches high, meaning it can be installed in areas that could not previously house a scanner with few structural modifications. Additionally, it uses less than 1 liter of helium with no need for a quench pipe for cooling.
According to company data, the scanner employs two image processing and artificial intelligence workflow innovations. Deep Resolve performs targeted de-noising and delivers higher-quality, higher-resolution images, and myExam Companion uses artificial intelligence to help users of all experience levels produce consistently high-quality images.
For more coverage based on industry expert insights and research, subscribe to the Diagnostic Imaging e-Newsletter here.
The Reading Room Podcast: Emerging Trends in the Radiology Workforce
February 11th 2022Richard Duszak, MD, and Mina Makary, MD, discuss a number of issues, ranging from demographic trends and NPRPs to physician burnout and medical student recruitment, that figure to impact the radiology workforce now and in the near future.
FDA Clears Magnetic Resonance Spectroscopy Platform for Non-Invasive Assessment of Brain Chemistry
November 29th 2023BrainSpec Core reportedly offers enhanced sensitivity for low-grade gliomas and may facilitate the diagnosis of conditions including Alzheimer’s disease, multiple sclerosis, and epilepsy.
Study: Black Patients Less Likely Than Others to Receive MRI Assessment of Cognitive Impairment
November 27th 2023In a four-year study of over 1,600 patients who had outpatient head CTs, head CT angiography and/or brain MRI to assess cognitive impairment, researchers found that Black patients were over 9 percent less likely than White patients and over 16 percent less likely than Hispanic patients to receive brain MRI.
